ICT-69

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameICT-69
Drug Alias Namemonoclonal antibody (ImmunoCellular Therapeutics)neoplasm diagnostic agent (ImmunoCellular Therapeutics)ICT-69
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionT lymphocytes inhibitors
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A